Krebs–Henseleit solution

Krebs–Henseleit solution, developed by Hans Krebs and Kurt Henseleit, is a solution containing sodium (Na), potassium (K), chloride (Cl), calcium (Ca), magnesium sulfate (MgSO₄), bicarbonate (HCO₃), phosphate (PO₄), glucose, albumin, and tromethamine (THAM).[1]

It has been used experimentally, for instance to study arteries ex vivo[2] and during isolated muscle testing of mammalian skeletal muscles.

References

curehunter.com > Krebs–Henseleit solution Retrieved on April 14, 2010
Quan A, Leung SW, Lao TT, Man RY (December 2003). "5-hydroxytryptamine and thromboxane A2 as physiologic mediators of human umbilical artery closure". J. Soc. Gynecol. Investig. 10 (8): 490–5. doi:10.1016/S1071-5576(03)00149-7. PMID 14662162.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] urehunter.com > Krebs–Henseleit solution Retrieved on April 14, 2010

[2] Quan A, Leung SW, Lao TT, Man RY (December 2003). "5-hydroxytryptamine and thromboxane A2 as physiologic mediators of human umbilical artery closure". J. Soc. Gynecol. Investig. 10 (8): 490–5. doi:10.1016/S1071-5576(03)00149-7. PMID 14662162.